Hypnic headache: A review of 348 cases published from 1988 to 2018

Silva‐Néto, Raimundo Pereira; Santos, Patrick Emanuell Mesquita Sousa; Peres, Mário Fernando Prieto

doi:10.1016/j.jns.2019.04.028

Cited by 35 publications

(59 citation statements)

References 75 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The first cases were described by Raskin in 1988 (1). Since then, more than 340 cases have been reported in the literature (2). Most of the individuals are older than 50 years and hypnic headache has been reported to be more common in women than men by a ratio of 2:1 (2,3).…”

Section: Introductionmentioning

confidence: 99%

“…Since then, more than 340 cases have been reported in the literature (2). Most of the individuals are older than 50 years and hypnic headache has been reported to be more common in women than men by a ratio of 2:1 (2,3). It is generally believed to be an uncommon disorder, but the prevalence is not known since studies on this are lacking (3).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The prevalence of hypnic headache in Iceland

et al. 2020

View full text Add to dashboard Cite

Objective To determine the prevalence of hypnic headache. Background The exact prevalence of hypnic headache is unknown since there are no published population-based prevalence studies. Methods This study was a pilot for the SAGA cohort study, a population-based study on life stressors and various indices of health. Of 1398 invited adults, 921 (66%) participated; 402 men (average age 45.6 years, SD 13.2) and 519 women (52.6 years, SD 11.1). Subjects answered a headache questionnaire including a screening question for hypnic headache. “Do you have a headache that occurs only during sleep and causes wakening?”. Diagnosis of hypnic headache was made by clinical interview using ICHD-3 criteria. Results Among 921 participants, six screened positive for hypnic headache, of those two 0.22% (95% CI 0.06–0.79%) had probable hypnic headache and none had definite hypnic headache. Conclusion Confirming that hypnic headache is rare, these data suggest a 0.22% prevalence of probable hypnic headache.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The prevalence of hypnic headache in Iceland

et al. 2020

View full text Add to dashboard Cite

show abstract

“…An MRI examination of the brain was normal, ruling out a structural lesion of the brain (Figure 1). Hypnic headaches were diagnosed, noting that less than 10% of patients present with occipital headaches [1]. Occipital neuralgia was excluded by the lack of sharp occipital pains, lack of tenderness over the occipital groove, and the absence of occipital pain with neck extension or rotation.…”

Section: Case Presentationmentioning

confidence: 99%

“…There is sexual dimorphism; approximately two-thirds of patients are women and one-third are men. Three-quarters of patients go into remission with caffeine, lithium, melatonin, or indomethacin [1]. There have also been isolated case reports of therapeutic responses to acetazolamide, topiramate, and the gabanoids (gabapentin and pregabalin) [2][3][4].…”

Section: Introductionmentioning

confidence: 99%

Hypnic Headache Responds to Topiramate: A Case Report and a Review of Mechanisms of Action of Therapeutic Agents

Kesserwani¹

2021

Cureus

View full text Add to dashboard Cite

Hypnic headaches are unique as they are exclusively nocturnal, occurring in rapid-eye movement (REM) and non-REM sleep. Their nocturnal nature suggests a role for cyclic mechanisms involving the hypothalamus despite conflicting imaging results for the role of the posterior hypothalamus. Nevertheless, pharmacological therapeutics acting as highly effective agents, such as caffeine and melatonin, can modulate the sleep-wake cycle. In addition, indole agents such as indomethacin that are anti-nociceptive and affect cerebral blood flow also prove to be efficacious. Gabanoids and topiramate also have reported efficacy. We report the case of a topiramate-responsive hypnic headache patient and outline in detail the potential mechanisms of topiramate and the other therapeutic agents and adumbrate on the neuronal networks of migraine, the trigeminal autonomic cephalgias and suggest a potential neural circuit for hypnic headaches.

show abstract

“…It is characterized by recurrent nocturnal episodes of headache that periodically awaken the sleeping patient. Its pathogenesis is unknown 33 . It occurs for 10 or more days per month, for more than 3 months and lasts >15 minutes and for up to 4 hours after waking up.…”

Section: Primary Headachesmentioning

confidence: 99%

A Historical Review of Headaches: Who First Described Them and When did This Occur?

Souza¹,

Sousa-Santos²,

Silva‐Néto³

2020

Headache

Self Cite

View full text Add to dashboard Cite

Background Headache is as old as human history and has been able to report, and the first descriptions were found in Greece and Mesopotamia. Objective Our objective was to know the date of the first description of ICHD‐3 headaches, with their respective author. Methods We searched for articles that addressed the historical aspects of primary and secondary headaches and painful cranial neuropathies. Results Twenty‐seven different headaches were analyzed according to the occurrence of their first description, with the respective author and country of origin. Conclusions The knowledge of the first description of ICHD‐3 headaches, with their respective author, showed us how and when the different headaches appeared over the years.

show abstract

Hypnic headache: A review of 348 cases published from 1988 to 2018

Cited by 35 publications

References 75 publications

The prevalence of hypnic headache in Iceland

The prevalence of hypnic headache in Iceland

Hypnic Headache Responds to Topiramate: A Case Report and a Review of Mechanisms of Action of Therapeutic Agents

A Historical Review of Headaches: Who First Described Them and When did This Occur?

Contact Info

Product

Resources

About